My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organigram Global Inc. - Common Shares (NQ:OGI)

1.890 +0.020 (+1.07%)
Streaming Delayed Price Updated: 11:50 AM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organigram Global Inc. - Common Shares

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Organigram to Report Fourth Quarter and Full Year Fiscal 2021 Results on November 23, 2021
From Organigram Holdings Inc.
Via Business Wire
Why This Cannabis Operator Is Giving Off Buy Signals
Could positive Q4 earnings reverse Organigram's recent stock slide? 
Via The Motley Fool
Topics Cannabis
Why Tilray Led Canadian Cannabis Stocks Higher Today
Election Day in the U.S. spurs hope for the future opening of a massive new market. 
Via The Motley Fool
Topics Cannabis
What Can Help Canopy Growth Reach $250M In Sales? Analyst's Thoughts Ahead Of Earnings
Canopy Growth Corporation (TSX:WEED) (NASDAQ: 
Via Benzinga
Organigram Provides Corporate Update
From Organigram Holdings Inc.
Via Business Wire
Cannabis Stocks Continued Their Decline Last Week
Cannabis stocks have been declining monthly since peaking on February 10th and, unfortunately, that trend continues. The Index was down another -1.5% last week and is now down -18.5% YTD. 
Via Talk Markets
Topics Cannabis
Why Tilray Stock Jumped 10% This Week -- While Other Cannabis Names Didn't
News from Tilray this week included adding to its management team and signing a new distribution agreement. 
Via The Motley Fool
Topics Cannabis
Why Sundial, Tilray, and OrganiGram Stocks Are Glowing Green Today
MJBizCon 2021 sounded some hopeful notes for marijuana investors. 
Via The Motley Fool
Topics Cannabis
California Governor Signs Historic Bill to Legalize Smokable Hemp and CBD Edibles
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 19, 2021 – Nearly four years after legalizing recreational marijuana, California has finally opened the path to make... 
Via FinancialNewsMedia
Topics Cannabis
Cannabis Stocks Continue To Crater
Our Pure-Play 
Via Talk Markets
Topics Cannabis
Why Tilray and Canopy Growth Were Among Rising Cannabis Stocks Today
Another acquisition agreement shows Canadian companies are positioning for a future legal U.S. market. 
Via The Motley Fool
Topics Cannabis
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program
The Week In Psychedelics 
Via Benzinga
Cannabis Movers & Shakers: Clairvoyant Therapeutics, Eaze, Leafly, Chalice Brands
As Benzinga Cannabis Capital Conference returns in a live format thi... 
Via Benzinga
Topics Cannabis
Forget The Hype, Most Cannabis Stocks Are Down YTD
We keep reading the hype about the cannabis sector doing extremely well but sizeable pure-play companies are down -13.1% YTD, on average. 
Via Talk Markets
Topics Cannabis
Former Tilray CEO Joins Psychedelics Company
More big names in cannabis are switching to psychedelics. Greg Engel, former CEO of Tilray (NASDAQ: 
Via Benzinga
Topics Cannabis
Why Green Thumb Industries, Canopy Growth, and OrganiGram Holdings Stocks All Popped Today
Pennsylvania plans to become the 19th state to legalize marijuana. 
Via The Motley Fool
Topics Cannabis
September Update: Cannabis LP Vs. MSO Performance Comparison
A look at which index outperformed in September. 
Via Talk Markets
Topics Cannabis
3 Cannabis Stocks to Avoid in October
Although the U.S. cannabis industry has been gaining steam due to the legalization of recreational marijuana in several states, there continue to be major obstacles including legalization at the... 
Via Talk Markets
Topics Cannabis
Why Tilray and Other Pot Stocks Jumped Today
The House of Representatives will vote on a bill this week that could be a game-changer in terms of how cannabis companies do business in the U.S. 
Via The Motley Fool
Topics Cannabis
11 Cannabis Stocks That Have Moved Significantly In September
During the last quarter, the cannabis sector has been under pressure and we have not seen the normal post-summer rally. 
Via Talk Markets
Topics Cannabis
Only 2 of These 11 Cannabis Stocks Have Traded Higher in September
During the last quarter, the cannabis sector has been under pressure and we have not seen the normal post-summer rally. 
Via Talk Markets
Topics Cannabis
CBD-Infused Products Market Expected To Reach $216.8 Billion By 2028
Via FinancialNewsMedia
Topics Cannabis
VIDEO: Cannabis Sales Booming Going Into Q4 - Red White And Bloom CEO On Key US Markets
Benzinga’s 
Via Benzinga
Topics Cannabis
Organigram On Pace To Beat Tilray And Hexo In QoQ Sales Growth As Canadian Rec. Sales Reach $275.6M
As COVID-related restrictions begin to ease across the globe, some industries are feeling the benefits more than others. When it comes to ... 
Via Benzinga
InterCure To Buy Strategic Assets From Cannomed On Heels Of Its NASDAQ Debut
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) revealed on Thursday that it will buy strategic assets from Cannomed (TASE: ... 
Via Benzinga
Israeli Cannabis Co. InterCure Begins Trading On NASDAQ, Chaired By Former Prime Minister
One of Israel’s largest cannabis companies, InterCure Ltd. (NASDAQ: 
Via Benzinga
Topics Cannabis
Organigram Holdings Inc. Files Final Base Shelf Prospectus
From Organigram Holdings Inc.
Via Business Wire
The Canadian Cannabis Report - Monday, Aug. 30
For the trading week ended August 27, my proprietary Canadian Cannabis Company Index (MCCCI) increased by 4.7% compared to the prior week when it decreased by 11.2%. 
Via Talk Markets
Topics Cannabis
Marijuana Stocks Had A Better Week, With Canadian LPs Gaining Lost Ground
In comparison to last Sunday's report, this week our Canadian Pure-Play Licensed Producers (LPs) Pot Stocks outpaced the American Multi-State Operators (MSOs) Pot Stocks. 
Via Talk Markets
Topics Cannabis
21 Stocks Moving in Wednesday's Pre-Market Session
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.